Electricite de France (ELEN) Noticias

It in encouraging of what I see in the Histogram in the Weekly Chart showing that a new uptrend appears to be in the process of developing for AMD share price.

Hopefully that is going to continue for a full blown share price breakout next week.

We shall see.

Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months. They may also have understandably diverted some resources towards a successful MAA.

There is no regulatory "sufficiency" test, other than being better than the standard of care, if one exists. The article makes the case that blarcamesine is better than any approved AD drug. The FDA employs a risk/benefit analysis, and you want your drug candidate to more than offset any risks with

Changing the innards of a Chevy with Ferrari parts is a game changer. Learn about the Z06. Maybe you will appreciate what is set to occur when the cusip, name, and ticker changes in this instance. Ignorance is alive and well by folks old enough to know better. Sad!
https://www.detroitnews.com

Do you happen to have a link to that example you gave?

Is that the company claiming to make water from air lol ? I think I posted a lol awhile back.

Sorry to go off tilt..it's your fault. last one........killer:

https://www.youtube.com/watch?v=wwIJk0C0xY0

I remember a time when dimes and mojo were wildly praised for their claim that this stock would hit $1-$3 by June. Just like Robert Sullivan on their Facebook page.

It didn't.

Stop considering their posts. They know next to nothing.

By the way mojo - yo

which position will the EMA take? (conventional), or will they go outside the box and follow in the steps of the authors, making the MABs relevant to the decision. The EMA has hinted that they are not happy with the MABs. The question might be, will the EMA approve a drug that can show partial pos

A thug not even born here...smh.

Actually that's Smokey Robinson, of the baby boomer generation, but what's an education worth nowadays?

OTC is entering a golden age in 2025 - Chartmaster.

With news, BIEL could lead the way!

While I know nothing about the specific trial, as I see it if the regulators accept the protocol of a specific trial they're also accepting the fact that if results warrant, they'll approve the drugs in the trial. It's up to the company to establish the acceptance criteria, which the regulator acce

The regulatory authorities don't care who is speaking at a conference, they just care what is submitted as part of a drug application.

BTW, I happen to think personal testimony is a gimmick that will not impress cynical executives.

People just don't understand how the Otc works!! If they say it runs it runs!! Doesn't matter if you like the fundamentals!!

There it is! The MONDAY COULD BE EXCITING for the 457th time in 13 months!

85%+ Monday PR releases and this user is betting on an update at anytime (no shit) and is picking... MONDAY!

That folks is what we call a sure bet and staying the obvious.

That bei

Pick 4 Contest #21 Contest Info. In.

Hope everyone enjoys. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-21-46064

Pick 4 Contest #21 Contest Info. In.

Hope everyone enjoys. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-21-46064

Interview with Intel CEO

https://www.youtube.com/watch?v=DpJqRHFYUqk

I just bought a beautiful sporty looking SUV and it cost me almost 50K come on avxl I'm counting on you I got to get that money back LOL

Same here with the red 'Stang. Let's make some cash!

Don't let the paid shills fluster yah. Just know when they come at yah it's because you're speaking valid truth. That threatens their failing ruse. Oh, and thanks to JPS lawyers for making the case for commons while trying to rob them a second time :-D

Hindenburg has targeted CARVANA now CV*NA. Citron short seller is backing NBI*S and pounding the table saying it is severely undervalued and a hidden gem, sees short term 60 dollars. I can't wait to see them buried alive on SMCI, provided that they haven't covered yet, betting they have already.

Gary,

About the number of compassionate use patients, I think there are a lot. I went through this before.

You can see in June 2023 Dr. Bosch mentioned about 600 patients in his presentation while at the end of August Les mentioned that about 800 patients received the t

Earth to mojo? Can you defend your position? No? Thought so.

Stop posting.